Observations obtained during the first 6 mo. of a psychoanalytically oriented psychotherapeutic procedure, capable of shortening and easing the initial phase of psychotherapy of LSD users, are reported. This procedure consisted of combined individual and group therapy, adding the LSD users to open mixed groups of abstinent patients. This procedure enabled the LSD users to participate in psychoanalysis, using the classical procedure, within less than 6 mo. Specific character trends and the underlying psychodynamic processes are also suggested. These processes appear to be specific for the LSD user and differ from those of the heroin addict and the chronic alcoholic.
Get full access to this article
View all access options for this article.
References
1.
AndenN. E.CorrodiH.FuxeK., & HokfeltT.Evidence for a central 5-hydroxy-triptamine receptor stimulation by lysergic acid diethylamide. Brit. J. Pharmacol., 1968, 34, 1–7.
2.
ApterJ. T., & PfeifferC. C.The effect of the hallucinogenic drugs LSD-25 and mescaline on the electroencephalogram. Ann. N. Y. Acad. Sci., 1957, 66, 508–514.
3.
BlumenfieldM., & GlickmanL.Ten months experience with LSD users admitted to county psychiatric receiving hospital. N. Y. State J. Med., 1967, 67, 1849–1854.
4.
ChafetzM. Z.Alcoholism. In FreedmanA. M.KaplanH. I., & KaplanH. S. (Eds.), Comprehensive textbook of psychiatry. Baltimore: Williams & Wilkins, 1967. Pp. 1011–1026.
5.
DavisV. E.BrownH.HuffJ. A., & CashawJ. L.The alteration of serotonin metabolism to 5-hydroxy-tryptophol by ethanol ingestion in man. J. lab. clin. Med., 1967, 69, 132–140.
6.
DavisV. E.BrownH.HuffJ. A., & CashawJ. L.Ethanol-induced alterations of norepinephrine metabolism in man. J. lab. clin. Med., 1967, 69, 787–799.
7.
EvartsE. V.A review of the neurophysiological effects of lysergic acid diethylamide (LSD) and other psychomimetic agents. Ann. N. Y. Acad. Sci., 1957, 66, 479–495.
8.
GoodmanL., & GilmanA.Pharmacological basis of therapeutics. Chicago: Saunders, 1966.
9.
HochP. H.CattellJ. P., & PennesH. H.Effects of mescaline and lysergic acid (d-LSD-25). Amer. J. Psychiat., 1952, 108, 579–584.
10.
HoffmannA.Psychomimetic drugs: chemical and pharmacological aspects. Acta Phys. Pharmacol. Neerl., 1959, 8, 240–258.
11.
HoffmannA.Psychomimetic substances. Indian J. Pharmacol., 1963, 25, 245–256.
12.
HolmesD.The adolescent in psychotherapy. Boston: Little, Brown, 1964.
13.
KillamK.Psychopharmacological considerations. In BlumR. (Ed.), Utopiates, the use and users of LSD-25. New York: Athernon, 1964. Pp. 118–123.
KrantzJ. C.Jr.CarrC. J., & La DuB. N.Jr.The pharmacological principles of medical practice. Baltimore: Williams & Wilkins, 1969.
16.
LangsR. J.Stability of earliest memories under LSD-25 and placebo. J. nerv. ment. Dis., 1967, 144, 171–184.
17.
LintonH. B.LangsR. J., & PaulJ. H.Retrospective alterations of the LSD-25 experience. J. nerv. ment. Dis., 1964, 138, 409–423.
18.
MuzioJ. N.RoffwargH. P., & KaufmanR.Alterations in the nocturnal sleep cycle resulting from LSD. EEG Clin. Neurophysiol., 1966, 21, 313–324.
19.
NyswanderM.The drug addict as a patient. New York: Grune & Stratton, 1956.
20.
PurpuraD.Experimental analysis of the inhibitory action of lysergic acid diethylamide on cortical dendritic activity. Ann. N. Y. Acad. Sci., 1957, 66, 515–537.
21.
SavageC.Variations in ego feeling induced by d-lysergic acid diethylamide (LSD-25). Psychol. Rev., 1955, 43, 1–15.
22.
StollW. A.Lysergsaure-diethyl-amid, ein Phantastikum aus der Mutterkorngruppe. Schweiz. Arch. Neur. Psychiat., 1947, 60, 279–323.
23.
ThompsonG. H.Acute and chronic alcoholic conditions. In ArietiS. (Ed.), American handbook of psychiatry. New York: Basic Books, 1959. Vol. 2. Pp. 1203–1221.
24.
TordaC.Combined group and individual therapy for adolescents with emotional disorder of functional origin. Excerpta Med. Int. Congress Ser., 1966, 150, 1681. (IV Int. Psychiatric Congress, 1966.) [Also, J. Psychother. in Groups, 1968, 2, 43–45.]
25.
TordaC.Comments on the character structure and psychodynamic processes of heroin addict. Percept. mot. Skills, 1968, 27, 143–146.
26.
TordaC.Contribution to the serotonin theory of dreaming (LSD infusion). N.Y. State J. Med., 1968, 68, 1135–1137.
27.
TordaC.An effective therapeutic procedure for the heroin addict. Percept. mot. Skills, 1968, 26, 753–755.
28.
TordaC.Observations on the initial phase of psychotherapy of LSD-users. IV. International Congress of Group Psychotherapy, Proceedings. Vienna: The Congress, 1968.
29.
TordaC.Observations on a physiological process related to dreaming. Communications in Behav. Biol., 1968, Part A, 2, 39–45.
30.
TordaC.Biochemical and bioelectric processes related to sleep, paradoxical sleep, and arousal. Psychol. Rep., 1969, 24, 807–824. (Monogr. Suppl. 2-V24)
31.
TordaC.Comments on the character structure and psychodynamic processes of LSD-users. N. Y. State J. Med., 1969, 69, 2243–2247.
